Regulation & Policy

Getty | Pilin Petunyia

WHO AI tool to clampdown on infant formula marketing

By Nikki Hancocks

The World Health Organisation (WHO) Europe is calling on consumers to use its newly developed artificial intelligence (AI) tool in order to clampdown and regulate the promotion of harmful products targeted at children.

Getty | James Kelley

GUEST POST

GOED perspective on the global fish oil supply

By Ellen Schutt, Managing Director, GOED

The global fish oil supply situation has been a hot topic in recent months, since the cancellation of the first anchovy fishing season in the North Central region of Peru in June.

Getty | CharlieAJA

Expert Opinion

ESSNA Insights: Navigating the EU-UK regulatory divergence

By Luca Bucchini

Since Brexit and the subsequent EU-UK Trade and Cooperation Agreement (TCA) in January 2021, UK’s departure from the EU has caused significant challenges for the sports and active nutrition sector and the wider food industry, bringing important regulatory...

Headline news roundup: August 2023

Headline news roundup: August 2023

By Olivia Haslam

During August, the industry was inspired by reports on consumer trends, welcomed a next step in probiotic harmonisation, discovered further AI technology advances, and encountered regulatory clarity issues.

Getty

Experts react to new health and nutrition claim proposals

By Olivia Brown

A number of regulatory experts have spoken out following the proposals published by the UK Office for Health Improvements and Disparities (OHID) last week, which suggested introducing improvement notices to improve adherence to health and nutrition claim...

GETTY | 24k production

The ACI puts pressure on UK Home Office to set THC limit

By Nikki Hancocks

The founder of the CBD consortium, the ACI (the Association for the Cannabinoid Industry), is putting the pressure on the UK Home Office in a bid to bring some legal clarity and ultimately closure to the seemingly halted CBD Novel Foods process.

News Round-Up July 2023

News roundup: July 2023

By Olivia Haslam

This month, the industry has encountered environmental campaign concerns, regulatory hinderance, nutrition recommendation improvements, and an abundance of research.

Getty | jarun011

New vitamin B12 guidance for UK doctors

By Nikki Hancocks

General Practitioners (GPs) in the UK are advised to offer patients a blood test for vitamin B12 deficiency if they see one symptom and one risk factor, in new guidance currently under consultation.

getty | law diccar

Guest Post

Embracing the ‘Art of the Possible’ in Novel Food Regulation

By David Hardstaff and John Binns

In this guest article, David Hardstaff and John Binns, Partners at BCL Solicitors, discuss a high-profile investigation into banned muscle-building drugs which highlights issues with the novel foods regime impacting the CBD industry.

GettyImages - Online Regulations /  Dragon Claws

Mushroom powders brand Dirtea removes adverts after ASA ruling

By Olivia Haslam

Dirtea Ltd, the mushroom powder supplements brand, has come under scrutiny by the Advertising Standards Authority (ASA) after making claims on its social media platforms that implied their products could prevent, treat, or cure human diseases.

Getty | Jorruang

Jersey Hemp shut down after UK Home Office action

By Nikki Hancocks

The only farm in the British Isles growing hemp and CBD extract onsite to create wellness products has shut down after the UK Home Office took action to stop export of its products to the UK.

GettyImages - CBD and AI / PrathanChorruangsak

CBD alliance to benefit from AI technology

By Olivia Haslam

The Association for the Cannabinoid Industry (ACI) and the Centre for Medicinal Cannabis (CMC) have formed a strategic partnership with Chem ID Ltd, a provider of chemical data standardisation, validation, and traceability solutions.

Getty

Aligning mindsets for sustainable supplements

By Olivia Brown

Players within the health and supplement sector must come together to achieve united agreements on health policies and sustainability goals, agreed experts during the IADSA World Supplement Forum last week.

© Vepar5 / Getty Images

Guest Article

Novel Foods: Half of new applications terminated for the same reason

By Andrea Almagro & Luis Gosálbez, Sandwalk BioVentures

A big wave of EFSA terminations of new Novel Food applications has happened over the last months, and all rejections have a common denominator – non-compliance with the Transparency Regulation.

Getty | MarianVejcik

Kemin's BetaVia Pure gains positive EFSA opinion

By Nikki Hancocks

Kemin Human Nutrition and Health’s 95% pure betaglucan ingredient BetaVia Pure is to be made available across Europe after gaining a positive EFSA opinion in response to its Novel Foods application.